PREVACID NAPRAPAC 375 (COPACKAGED) Drug Patent Profile

✉ Email this page to a colleague

When do Prevacid Naprapac 375 (copackaged) patents expire, and what generic alternatives are available?

Prevacid Naprapac 375 (copackaged) is a drug marketed by Takeda Pharms Na and is included in one NDA.

The generic ingredient in PREVACID NAPRAPAC 375 (COPACKAGED) is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PREVACID NAPRAPAC 375 (COPACKAGED)?
What are the global sales for PREVACID NAPRAPAC 375 (COPACKAGED)?
What is Average Wholesale Price for PREVACID NAPRAPAC 375 (COPACKAGED)?

Summary for PREVACID NAPRAPAC 375 (COPACKAGED)

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	PREVACID NAPRAPAC 375 (COPACKAGED) at DailyMed

Drug patent expirations by year for PREVACID NAPRAPAC 375 (COPACKAGED)

US Patents and Regulatory Information for PREVACID NAPRAPAC 375 (COPACKAGED)

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Takeda Pharms Na	PREVACID NAPRAPAC 375 (COPACKAGED)	lansoprazole; naproxen	CAPSULE, DELAYED REL PELLETS, TABLET;ORAL	021507-003	Nov 14, 2003		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for PREVACID NAPRAPAC 375 (COPACKAGED)

See the table below for patents covering PREVACID NAPRAPAC 375 (COPACKAGED) around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Spain	8607288		⤷ Subscribe
Spain	546152		⤷ Subscribe
Bulgaria	60415		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for PREVACID NAPRAPAC 375 (COPACKAGED)

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0174726	SPC/GB94/011	United Kingdom	⤷ Subscribe	SPC/GB94/011, EXPIRES: 20051210
0174726	93C0021	Belgium	⤷ Subscribe	PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for PREVACID NAPRAPAC 375 (COPACKAGED)

Make Better Decisions: Try a trial or see plans & pricing